The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
Published in: | BMC Anesthesiology 22(2022)S. 12 |
---|---|
Main Authors: | Unterberg, Matthias (Author), Rahmel, Tim (Author), Köhler, Thomas (Author), Henzler, Dietrich (Author), Schwier, Elke (Author) |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://doi.org/10.1186/s12871-021-01547-8 |
Related Items: | In:
BMC Anesthesiology |
Similar Items
-
Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
by: Kirchner, Carmen, et al.
Published: (2019) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
by: Köhler, Thomas, et al.
Published: (2021) -
Interrupted Chain of Transmission in a Pediatric COVID-19 Case
by: Grautoff, Steffen
Published: (2020) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
by: Köhler, Thomas, et al.
Published: (2022) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
by: Schwier, Elke, et al.
Published: (2021)